Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Volpe

Showing results (301-310 of 821) with videos related to

Pageof 83
Sort By:
Current Medical Research and Opinion|March 22, 2023
Extemporaneous combination therapy with amlodipine/zofenopril in hypertensive patients: a real-world data analysis in ItalyMassimo Volpe, Valeria Pegoraro, Franca Heiman, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Aldosterone synthesis inhibitors in resistant hypertension: the BaxHTN trialGiovanna Gallo, Maurizio Volterrani, Giuliano Tocci, et al.
Journal of Cardiovascular Pharmacology|June 20, 2012
Pharmacological modulation of autophagy during cardiac stressSebastiano Sciarretta, Peiyong Zhai, Massimo Volpe, et al.
Clinical Interventions in Aging|October 23, 2015
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelinesStefano Omboni, Ettore Malacco, Jean-Michel Mallion, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|October 13, 2025
Hypertension International Guidelines: Three of a Kind?Agostino Virdis, Maria Lorenza Muiesan, Guido Grassi, et al.
American Journal of Hypertension|May 7, 2002
ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: the end of the search or a need for further investigations?Luis M Ruilope, Antonio Coca, Massimo Volpe, et al.
Drugs & Aging|November 27, 2012
Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly mild to moderate essential hypertensive patients with or without metabolic syndrome: a pooled post hoc analysis of two comparative trialsStefano Omboni, Ettore Malacco, Jean-Michel Mallion, et al.
Diabetes|May 25, 2013
SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands togetherFrancesco Paneni, Massimo Volpe, Thomas Felix Lüscher, et al.
Cardiovascular Research|July 6, 2024
Advances in nucleic acid-targeted therapies for cardiovascular disease preventionUmidakhon Makhmudova, Elisabeth Steinhagen-Thiessen, Massimo Volpe, et al.
Clinical Drug Investigation|August 23, 2012
Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combinationMassimo Volpe, Lars Christian Rump, Bettina Ammentorp, et al.
Pageof 83

Showing results (301-310 of 821) with videos related to

Sort By:
Pageof 83
Current Medical Research and Opinion|March 22, 2023
Extemporaneous combination therapy with amlodipine/zofenopril in hypertensive patients: a real-world data analysis in ItalyMassimo Volpe, Valeria Pegoraro, Franca Heiman, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Aldosterone synthesis inhibitors in resistant hypertension: the BaxHTN trialGiovanna Gallo, Maurizio Volterrani, Giuliano Tocci, et al.
Journal of Cardiovascular Pharmacology|June 20, 2012
Pharmacological modulation of autophagy during cardiac stressSebastiano Sciarretta, Peiyong Zhai, Massimo Volpe, et al.
Clinical Interventions in Aging|October 23, 2015
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelinesStefano Omboni, Ettore Malacco, Jean-Michel Mallion, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|October 13, 2025
Hypertension International Guidelines: Three of a Kind?Agostino Virdis, Maria Lorenza Muiesan, Guido Grassi, et al.
American Journal of Hypertension|May 7, 2002
ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: the end of the search or a need for further investigations?Luis M Ruilope, Antonio Coca, Massimo Volpe, et al.
Drugs & Aging|November 27, 2012
Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly mild to moderate essential hypertensive patients with or without metabolic syndrome: a pooled post hoc analysis of two comparative trialsStefano Omboni, Ettore Malacco, Jean-Michel Mallion, et al.
Diabetes|May 25, 2013
SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands togetherFrancesco Paneni, Massimo Volpe, Thomas Felix Lüscher, et al.
Cardiovascular Research|July 6, 2024
Advances in nucleic acid-targeted therapies for cardiovascular disease preventionUmidakhon Makhmudova, Elisabeth Steinhagen-Thiessen, Massimo Volpe, et al.
Clinical Drug Investigation|August 23, 2012
Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combinationMassimo Volpe, Lars Christian Rump, Bettina Ammentorp, et al.
Pageof 83